Ibex Investors’s NEOPHOTONICS CORP NPTN Stock Holding History

Ibex Investors’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,565	Closed	-$220K	–	269
2018 Q3	$220K	Buy	+26,565	New	+$202K	0.12%	61

Other funds holding NPTN

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ibex Investors's NPTN Position: Q4 2018 in Review

Ibex Investors sold out of NEOPHOTONICS CORP (NPTN) in Q4 2018, closing a stake of 26,565 shares — an estimated $220K sold.

Ibex Investors first reported a position in NPTN in Q3 2018 and held it in 1 quarter. The position peaked at $220K in Q3 2018. 115 funds tracked by Wall St. Rank hold NPTN as of Q4 2018.

Ibex Investors reported no remaining NEOPHOTONICS CORP position as of Q4 2018 after selling out during the quarter.
Ibex Investors sold 26,565 NEOPHOTONICS CORP shares in Q4 2018, an estimated $220K.
Ibex Investors first reported a position in NEOPHOTONICS CORP in Q3 2018 and held it in 1 quarter.
Ibex Investors's NEOPHOTONICS CORP position peaked at $220K in Q3 2018.
115 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2018.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.